Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2019 Mar;85(3):626-633.
doi: 10.1111/bcp.13840. Epub 2019 Jan 24.

Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers

Affiliations
Clinical Trial

Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers

Urs Duthaler et al. Br J Clin Pharmacol. 2019 Mar.

Abstract

Aims: The anthelminthic ivermectin is receiving new attention as it is being repurposed for new indications such as mass drug administrations for the treatment of scabies or in malaria vector control. As its pharmacokinetics are still poorly understood, we aimed to characterize the population pharmacokinetics of ivermectin in plasma and dried blood spots (DBS), a sampling method better suited to field trials, with special focus on the influence of body composition and enterohepatic circulation.

Methods: We performed a clinical trial in 12 healthy volunteers who each received a single oral dose of 12 mg ivermectin, and collected peripheral venous and capillary DBS samples. We determined ivermectin concentrations in plasma and DBS by liquid chromatography tandem mass spectrometry using a fully automated and scalable extraction system for DBS sample processing. Pharmacokinetic data were analysed using non-linear mixed effects modelling.

Results: A two-compartment model with a transit absorption model, first-order elimination, and weight as an influential covariate on central volume of distribution and clearance best described the data. The model estimates (inter-individual variability) for a 70 kg subject were: apparent population clearance 7.7 (25%) l h-1 , and central and peripheral volumes of distribution 89 (10%) l and 234 (20%) l, respectively. Concentrations obtained from DBS samples were strongly linearly correlated (R2 = 0.97) with plasma concentrations, and on average 30% lower.

Conclusion: The model accurately depicts population pharmacokinetics of plasma and DBS concentrations over time for oral ivermectin. The proposed analytical workflow is scalable and applicable to the requirements of mass drug administrations.

Keywords: Drug analysis; parasitology < Infectious diseases; pharmacokinetics; pharmacometrics; tropical diseases < Infectious diseases.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overview of the final structural model
Figure 2
Figure 2
Simulated concentration curve over 72 h for a hypothetical typical individual with a weight of 70 kg (solid line) together with the observed data from all volunteers enrolled in the study (dots), and confidence lines at 5% and 90% from 500 simulated volunteers (dashed lines)

References

    1. Chaccour C, Hammann F, Rabinovich NR. Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety. Malar J 2017; 16: 161. - PMC - PubMed
    1. Menez C, Sutra JF, Prichard R, Lespine A. Relative neurotoxicity of ivermectin and moxidectin in Mdr1ab (−/−) mice and effects on mammalian GABA(A) channel activity. PLoS Negl Trop Dis 2012; 6: e1883. - PMC - PubMed
    1. Ejere HO, Schwartz E, Wormald R, Evans JR. Ivermectin for onchocercal eye disease (river blindness). Cochrane Database Syst Rev 2012; 8: CD002219. - PMC - PubMed
    1. Mectizan Donation Program . Annual highlights 2015. Available at https://mectizan.org/wp‐content/uploads/2017/03/MDP_AnnHigh2015_Design‐0... (last accessed 6 June 2018).
    1. Romani L, Whitfeld MJ, Koroivueta J, Kama M, Wand H, Tikoduadua L, et al Mass drug administration for scabies control in a population with endemic disease. N Engl J Med 2015; 373: 2305–2313. - PubMed

Publication types

MeSH terms